Table 2.
Compound No. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
---|---|---|---|---|---|---|---|---|---|---|
DrugLikeness | Lipinski’s Rule of Five | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Bioavailability Score (%) | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | |
Absorption | Water Solubility | −3.91 | −2.93 | −2.82 | −2.64 | −3.81 | −2.55 | −3.17 | −1.11 | −4.59 |
Caco2 Permeability | 1.09 | 1.59 | 1.81 | 1.16 | 1.76 | 1.17 | 1.24 | 0.75 | 0.11 | |
Intestinal Absorption (Human) (%) | 98.97 | 94.99 | 93.80 | 94.58 | 98.05 | 94.77 | 97 | 77.02 | 68.16 | |
Skin Permeability | −5.33 | −6.75 | −6.74 | −6.90 | −5.64 | −6.99 | −6.92 | −8.23 | −7.83 | |
P-glycoprotein Substrate | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | |
P-glycoprotein Inhibitor | No | No | No | No | No | No | No | No | Yes | |
P-glycoprotein Inhibitor | No | No | No | No | No | No | No | No | No | |
Distribution | VDss(human) | −0.02 | 0.89 | 0.88 | 1.05 | 0.66 | 0.88 | 0.14 | 0.55 | 0.91 |
BBBpermeability | 0.15 | −0.08 | −0.02 | −0.15 | 0.25 | −0.09 | −0.32 | −0.75 | −0.64 | |
CNS permeability | −1.56 | −2.51 | −2.47 | −2.92 | −1.57 | −2.90 | −2.93 | −3.36 | −2.89 | |
Metabolism | CYP2D6 Substrate | No | No | Yes | Yes | No | No | No | No | No |
CYP3A4 Substrate | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | |
CYP2D6 Inhibitor | Yes | Yes | Yes | Yes | No | Yes | Yes | No | Yes | |
CYP3A4 Inhibitor | Yes | No | No | No | No | No | No | No | No | |
Excretion | Total Clearance | 0.21 | 0.99 | 1.12 | 1.07 | 0.14 | 1.09 | 1.02 | 0.58 | 0.47 |
Renal OCT2 Substrate | No | Yes | No | No | No | No | No | No | No | |
Toxicity | AMES Toxicity | Yes | No | Yes | No | Yes | No | No | Yes | No |
Hepatotoxicity | Yes | Yes | Yes | No | No | Yes | No | No | No | |
hERG I Inhibitor | No | No | No | No | No | No | No | No | No | |
hERG II inhibitor | No | Yes | No | No | No | No | No | No | Yes | |
Skin Sensitization | No | No | No | No | No | No | No | No | No | |
Maximal Tolerated Dose | 0.29 | −0.42 | −0.56 | −0.77 | −0.37 | −0.33 | −0.49 | −0.16 | −0.84 | |
Oral Rat Acute Toxicity (LD50) | 2.61 | 2.72 | 2.47 | 2.75 | 2.25 | 2.64 | 3.01 | 2.54 | 3.17 | |
Oral Rat Chronic Toxicity (LOAEL) | 2.03 | 0.96 | 1.2 | 1.45 | 1.58 | 1.25 | 0.69 | 2.31 | 2.81 | |
Minnow Toxicity | −0.32 | 1.67 | 2.24 | 2.09 | 0.42 | 2.09 | 2.08 | 1.89 | 3.37 | |
T. pyriformis toxicity | 0.35 | 0.78 | 0.76 | 0.28 | 1.24 | 0.39 | 0.45 | 0.27 | 0.28 |